The AstraZeneca PLC ADR
AZN,
inched 0.10% higher to $51.34 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index
COMP,
falling 0.87% to 12,998.50 and Dow Jones Industrial Average
DJIA,
falling 0.57% to 30,814.26. This was the ADR’s third consecutive day of gains. AstraZeneca PLC ADR closed $13.60 below its 52-week high ($64.94), which the company achieved on July 20th.
The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc.
ABBV,
fell 0.99% to $110.52, Amgen Inc.
AMGN,
rose 1.58% to $245.49, and Gilead Sciences Inc.
GILD,
rose 1.49% to $63.33. Trading volume (9.5 M) remained 1.4 million below its 50-day average volume of 10.9 M.
Editor’s Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.
Read More: AstraZeneca PLC ADR outperforms competitors on strong trading day